Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Rapid Therapeutic Science Laboratories, Inc. (RTSL) Shares Outstanding (Weighted Average) (2016 - 2023)

Rapid Therapeutic Science Laboratories' Shares Outstanding (Weighted Average) history spans 8 years, with the latest figure at $8.3 million for Q2 2023.

  • For Q2 2023, Shares Outstanding (Weighted Average) rose 7.39% year-over-year to $8.3 million; the TTM value through Jun 2023 reached $8.3 million, up 7.39%, while the annual FY2022 figure was $7.7 million, 1.54% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q2 2023 was $8.3 million at Rapid Therapeutic Science Laboratories, up from $8.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $168.8 million in Q4 2020 and bottomed at $1.2 million in Q1 2019.
  • The 5-year median for Shares Outstanding (Weighted Average) is $7.7 million (2022), against an average of $42.3 million.
  • The largest annual shift saw Shares Outstanding (Weighted Average) surged 13633.77% in 2020 before it tumbled 95.48% in 2021.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $27.2 million in 2019, then soared by 519.52% to $168.8 million in 2020, then plummeted by 95.48% to $7.6 million in 2021, then grew by 1.54% to $7.7 million in 2022, then increased by 7.37% to $8.3 million in 2023.
  • Per Business Quant, the three most recent readings for RTSL's Shares Outstanding (Weighted Average) are $8.3 million (Q2 2023), $8.0 million (Q1 2023), and $7.7 million (Q4 2022).